Theophylline
NDC 72578-174, Theophylline, tablet, extended release, from Viona Pharmaceuticals Inc.
- Product NDC
- 72578-174
- Status
- Listed
- Labeler
- Viona Pharmaceuticals Inc
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218063
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72578-174 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- THEOPHYLLINE ANHYDROUS450 mg/1
Pharmacologic classes
Methylxanthine [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72578-174-01 | 72578017401 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72578-174-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/abdfb9b9-9402-4761-9347-8eb1c4d86242NADAC price for package 72578017401
GET /v1/drugs/nadac/72578017401
Use it
Look up 72578-174 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72578-174 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72578-174. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.